The next wave in oncology: 7 innovations redefining cancer treatment in 2024 and beyond

Published on September 12, 2024

Oncology is undergoing a transformative shift, with new therapies and technologies driving significant improvements in cancer care. The Next Wave in Oncology explores seven groundbreaking advancements, from antibody-drug conjugates (ADCs) to artificial intelligence, that are redefining how cancer is treated. Staying up to date on these innovations is essential for those navigating the rapidly changing […]

Continue reading on website
Other news

5 Must-Dos to Ensure Successful Cell Line Development

September 11, 2024
Cell line development (CLD) is a cornerstone in the production of biologics, directly influencing the efficiency of the manufacturing process, the quality of the final product, and the overall success of a therapeutic program. However, the path to successful CLD isn’t always straightforward and can present many roadblocks if a drug developer isn’t aware of what to prioritize from the very start of

CHEManager International: Defining New Rules – The Evolution of the CDMO Industry

September 12, 2024
CHEManager International’s recent issue features an article from Gavin Murdoch, VP Commercial Strategy at Abzena. Gavin’s article took a look at the evolution of the CDMO sector as it is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.CHEManager asked executives and industry experts from a broad range of CDMOs to share